Viewing Study NCT02124512


Ignite Creation Date: 2025-12-26 @ 10:18 PM
Ignite Modification Date: 2026-02-25 @ 3:10 AM
Study NCT ID: NCT02124512
Status: COMPLETED
Last Update Posted: 2019-08-21
First Post: 2014-04-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Blood Lipopolysaccharide (LPS) Rifaximin Study
Sponsor:
Organization: